Thymosin β4 promotes dermal healing

This pioneering study published in the Journal of Investigative Dermatology was one of the first to systematically demonstrate the role of thymosin β4 (TB-500) in dermal healing. The researchers used cutaneous wound models in rats and in vitro cell assays to evaluate the multiple mechanisms by which the peptide accelerates tissue repair.

Thymosin β4 promoted healing through three main mechanisms: enhanced cell migration of keratinocytes and endothelial cells to the wound bed, stimulation of angiogenesis (formation of new blood vessels), and increased extracellular matrix deposition, including collagen. Wounds treated with TB-500 showed significantly faster closure than controls.

• Topical application of TB-500 accelerated wound closure in animal models
• In vitro, the peptide stimulated keratinocyte migration in a dose-dependent manner
• Angiogenesis was confirmed by increased blood vessels in granulation tissue
• The mechanism involved actin modulation, consistent with the known role of thymosin β4 as a G-actin sequestering protein

This work established the scientific foundation for subsequent investigation of thymosin β4 in various tissue repair applications, from chronic wound healing to cardiac regeneration, becoming a fundamental reference in the literature on regenerative peptides.